Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,339 public trials 1,980 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, Not Recruiting

Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)

NCT05501886

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Oncology (US Oncology/McKesson) - Goodyear Goodyear, Arizona, United States
  • St. Bernards Medical Center Jonesboro, Arkansas, United States
  • CARTI Cancer Center Little Rock, Arkansas, United States
View all 235 locations
View Trial Details
Active, Not Recruiting

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

NCT05239143

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +66 more
Locations
  • University of California, Irvine Medical Center Irvine, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer

NCT02308085

Conditions
Breast Diseases, Breast Neoplasms, Early Breast Cancer, +4 more
Locations
  • Cedars Sinai Medical Centre Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • University of Colorado Cancer Centre - Anschutz Cancer Pavilion Aurora, Colorado, United States
View all 211 locations
View Trial Details
Active, Not Recruiting

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

NCT04478279

Conditions
Astrocytoma, Brain Cancer, Brain Diseases, +43 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
  • Northwestern Medicine Cancer Centers Warrenville, Illinois, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details
Active, Not Recruiting

Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)

NCT04639986

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Cancer Hospital Chinese Academy of Medical Science Beijing, China
  • Chinese PLA General Hospital Beijing, China
  • Peking University People's Hospital Beijing, China
  • Jilin Cancer Hospital Changchun, China
View all 43 locations
View Trial Details
Active, Not Recruiting

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

NCT05333874

Conditions
Breast Cancer, Early-Onset, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Trinitas Hospital and Comprehensive Cancer Center Elizabeth, New Jersey, United States
  • RWJBarnabas Health - Robert Wood Johnson University Hospital Hamilton, New Jersey, United States
  • Jersey City Medical Center Jersey City, New Jersey, United States
  • Monmouth Medical Center - Southern Campus Lakewood, New Jersey, United States
View Trial Details
Active, Not Recruiting

A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer

NCT02747004

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
  • The Center for Cancer and Blood Disorders Fort Worth, Texas, United States
View all 59 locations
View Trial Details

Related conditions